Verona Pharma PLC (NASDAQ:VRNA)

Delayed Data
As of 11:50am ET
 +0.0131 / +0.32%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Verona Pharma PLC have a median target of 26.29, with a high estimate of 58.00 and a low estimate of 8.00. The median estimate represents a +545.82% increase from the last price of 4.07.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Verona Pharma PLC. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.80%
Growthannually -55.15%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.